New Lipoglycopeptides

2010/04/08 by George G. Zhanel, Divna Calic, Frank Schweizer +9 · 29 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Antimicrobial Resistance in Staphylococcus #Pneumonia and Respiratory Infections #Biochemical and Structural Characterization

paper · doi:10.2165/11534440-000000000-00000

Cited by

• Coagulase-Negative Staphylococci
• Resistance to last-resort antibiotics in enterococci
• Natural product and natural product derived drugs in clinical trials
• A Comprehensive Overview of Antimicrobial Peptides: Broad-Spectrum Activity, Computational Approaches, and Applications
• Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections. [europepmc]
• Messenger functions of the bacterial cell wall-derived muropeptides. [europepmc]
• New antibiotics for bad bugs: where are we? [europepmc]
• Investigational antimicrobial agents of 2013. [europepmc]
• Coagulase-negative staphylococci. [europepmc]
• Dalbavancin: A Novel Lipoglycopeptide Antibiotic with Extended Activity Against Gram-Positive Infections. [europepmc]
• Old and New Glycopeptide Antibiotics: Action and Resistance. [europepmc]
• What's new in multidrug-resistant pathogens in the ICU? [europepmc]
• Developments in Glycopeptide Antibiotics. [europepmc]
• Challenging the Drug-Likeness Dogma for New Drug Discovery in Tuberculosis. [europepmc]
• Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis. [europepmc]
• Impact on Public Health of the Spread of High-Level Resistance to Gentamicin and Vancomycin in Enterococci. [europepmc]
• Antimicrobial resistance in methicillin-resistant Staphylococcus aureus to newer antimicrobial agents. [europepmc]
• Development and Challenges of Antimicrobial Peptides for Therapeutic Applications. [europepmc]
• Resistance of Gram-Positive Bacteria to Current Antibacterial Agents and Overcoming Approaches. [europepmc]
• Resistance in Vancomycin-Resistant Enterococci. [europepmc]
• High-speed atomic force microscopy highlights new molecular mechanism of daptomycin action. [europepmc]
• Population pharmacokinetics of dalbavancin and dosing consideration for optimal treatment of adult patients with staphylococcal osteoarticular infections. [europepmc]
• Review: A Safety Profile of Dalbavancin for On- and Off-Label Utilization. [europepmc]
• Mechanisms of Antibiotic Resistance in Important Gram-Positive and Gram-Negative Pathogens and Novel Antibiotic Solutions. [europepmc]
• The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions. [europepmc]
• Recent Advances in the Development of Semisynthetic Glycopeptide Antibiotics: 2014-2022. [europepmc]
• Structure-activity relationships of antibacterial peptides. [europepmc]
• Therapeutics for Vancomycin-Resistant Enterococcal Bloodstream Infections. [europepmc]
• Antimicrobial Peptides towards Clinical Application-A Long History to Be Concluded. [europepmc]